{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:43:02Z","timestamp":1782996182725,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Myaware"},{"name":"Clinical Research Fellowships"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jneuroim.2020.577149","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T12:16:44Z","timestamp":1578658604000},"page":"577149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome"],"prefix":"10.1016","volume":"340","author":[{"given":"Paul","family":"Maddison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gozzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girija","family":"Sadalage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Ambrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2020.577149_bb0005","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1212\/WNL.0b013e318247cd03","article-title":"GABAB receptors: structure, functions, and clinical implications","volume":"78","author":"Benarroch","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-5728(00)00431-8","article-title":"Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line","volume":"113","author":"Benatar","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","article-title":"GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders","volume":"76","author":"Boronat","year":"2011","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0020","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/epi.12127","article-title":"Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy","volume":"54","author":"Brenner","year":"2013","journal-title":"Epilepsia."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0025","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/1078-0432.CCR-10-1363","article-title":"Immunobiomarkers in small cell lung cancer: potential early cancer signals","volume":"17","author":"Chapman","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/01616412.2017.1351062","article-title":"Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission","volume":"39","author":"Chen","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.24745","article-title":"Repetitive nerve stimulation and single-fiber electromyography in the evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: review of recent literature","volume":"52","author":"Chiou-Tan","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2020.577149_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/CND.0000000000000192","article-title":"Paraneoplastic lambert-eaton myasthenic syndrome with limbic encephalitis: clinical correlation with the coexistence of anti-VGCC and anti-GABAB receptor antibodies","volume":"19","author":"Cho","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0045","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2014.05.011","article-title":"Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel","volume":"273","author":"Dogan Onugoren","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0055","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","article-title":"Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series","volume":"86","author":"Dogan Onugoren","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2020.577149_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurological disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0065","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1073\/pnas.97.8.4198","article-title":"Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer","volume":"97","author":"G\u00fcre","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0070","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0075","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/1078-0432.CCR-14-0652","article-title":"Neural autoantibody clusters aid diagnosis of cancer","volume":"20","author":"Horta","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0080","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","article-title":"GABAB receptor autoantibody frequency in service serologic evaluation","volume":"81","author":"Jeffery","year":"2013","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089426","article-title":"Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit","volume":"9","author":"Khakwani","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jneuroim.2020.577149_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0100","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.0000000000003794","article-title":"Long term survival in paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"88","author":"Maddison","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2018.11.003","article-title":"The utility of anti-SOX2 antibodies for cancer prediction in patients with paraneoplastic neurological disorders","volume":"326","author":"Maddison","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0110","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer. [Review]","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(96)05303-8","article-title":"Incidence of serum anti-P\/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome","volume":"147","author":"Motomura","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/annonc\/mdp606","article-title":"Technical validation of an autoantibody test for lung cancer","volume":"21","author":"Murray","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The Lambert-Eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O\u2019Neill","year":"1988","journal-title":"Brain."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mus.20389","article-title":"Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome","volume":"32","author":"Oh","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2020.577149_bb0135","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1200\/JCO.2008.17.5133","article-title":"Screening for small-cell lung cancer: a follow-up study of patients with Lambert-Eaton myasthenic syndrome","volume":"26","author":"Titulaer","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0140","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0145","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0150","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1474-4422(11)70245-9","article-title":"Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies","volume":"10","author":"Titulaer","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2020.577149_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mus.25027","article-title":"P\/Q- and N-type calcium-channel antibodies: oncological, neurological, and serological accompaniments","volume":"54","author":"Zalewski","year":"2016","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819306526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819306526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:34:37Z","timestamp":1759048477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819306526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":31,"alternative-id":["S0165572819306526"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577149","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577149"}}